Is Individual Operator Experience Important in TAVR?

Courtesy of Dr. Carlos Fava.

Transcatheter aortic valve replacement (TAVR) has emerged as a successful alternative for inoperable patients and a non-inferior alternative for high- and intermediate-risk patients. While its evolution depending on site experience has been analyzed, there is currently very little information regarding the impact of operator individual experience.

Terapia endovascular en stroke: mucha evidencia y pocos operadores entrenadosThis study analyzed 8771 procedures performed by 207 different operators. High-volume operators were defined as those performing ≥80 procedures/year; intermediate-volume operators were those performing between 24 and 79 procedures/year, and low-volume operators, <24 procedures/year. The “learning curve” of these operators was excluded so as to mitigate the incidence of complications that could bias results.

 

Patients of high-volume operators had a significantly lower in-hospital risk for death, stroke, and acute myocardial infarction (odds ratio: 0.59; 95% confidence interval [CI]: 0.37 to 0.93) compared with low-volume operators.


Read also: PCI Mortality and Volume in One Center: Associated?


Patients of operators who performed >200 procedures during the prior year had a significantly lower risk for post-procedural stroke (odds ratio: 0.41; 95% confidence interval: 0.17 to 0.97) and less in-hospital events (odds ratio: 0.45; 95% confidence interval: 0.26 to 0.78).

 

Conclusion

Increased operator experience is associated with improvement in risk-adjusted in-hospital progress. These results are potentially important for individual training and hospital programs in TAVR.

 

Courtesy of Dr. Carlos Fava.

 

Original title: Individual Operator Experience and Outcomes in Transcatheter Aortic Valve Replacement.

Reference: Arash Salemi et al. Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...

J-Valve for Chronic AR: 30-Day Outcomes of Transfemoral Valve J-Valve in Chronic Aortic Regurgitation

Chronic aortic regurgitation (AR) poses a significant challenge as far as transcatheter alternatives go due to the absence of calcification and a suitable anchoring...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...